» Articles » PMID: 29306787

Building Cancer Registries in a Lower Resource Setting: The 10-year Experience of Golestan, Northern Iran

Abstract

Introduction: The Golestan population-based cancer registry (GPCR) was established in Golestan province, Northern Iran, within the Asian belt with predominance of upper-gastrointestinal cancers. We aimed to present the experiences of the registry in a resource-limited setting over the 10 years since its inception (2004-2013).

Methods: The GPCR was established as a research project to enable sustainable funding. A clear plan was developed for use of the GPCR data. New primary cancers were registered based on international standards, indices of data quality were routinely assessed and age-standardized incidence rates (ASR) per 100,000 person-years calculated using IARC's CanReg-5 software.

Results: Overall, 19807 new cancer cases were registered during the study period, an average of 1981 cases per annum, with overall ASR of 175.0 and 142.4 in males and females, respectively. The GPCR data suggested gastrointestinal and breast cancers as the most common malignancies in Golestan province. We observed increasing incidence rates of breast and colorectal cancers but declining trends of esophageal cancer. Overall, indices of data quality were within acceptable ranges.

Conclusions: The GPCR data have been included in IARC's Cancer Incidence in Five Continents series, were used in 21 research projects, and published as 30 research papers. The key ingredients for the successful establishment and maintenance of the GPCR included sustainable sources of funding, a clear action plan for the use of data as well as stakeholder cooperation across all areas of the registration. The GPCR may be considered as a model for planning population-based cancer registries in lesser-resourced settings.

Citing Articles

Incidence Rates and Time Trends of Pancreatic Cancer in the Golestan Province, Northeastern Iran, 2006-2019.

Kaabe S, Amiriani T, Teimoorian M, Besharat S, Salamat F, Hasanpour-Heidari S Arch Iran Med. 2024; 27(9):486-493.

PMID: 39465523 PMC: 11496600. DOI: 10.34172/aim.31168.


Improvement of esophageal cancer survival in Northeast Iran: A two-decade journey in a high-risk, low- resource region.

Nemati S, Islami F, Kamangar F, Poustchi H, Roshandel G, Shakeri R PLoS One. 2024; 19(9):e0310842.

PMID: 39321196 PMC: 11423987. DOI: 10.1371/journal.pone.0310842.


A Bayesian approach to correct the under-count of cancer registry statistics before population-based cancer registry program.

Barati H, Pourhoseingholi M, Roshandel G, Hashemi Nazari S, Fattahi E Gastroenterol Hepatol Bed Bench. 2024; 16(4):421-431.

PMID: 38313354 PMC: 10835089. DOI: 10.22037/ghfbb.v16i4.2843.


Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry.

Ashkbari A, Amlashi F, Besharat S, Mofidi M, Amiriani T, Fazel A Arch Iran Med. 2024; 26(9):504-509.

PMID: 38310406 PMC: 10862055. DOI: 10.34172/aim.2023.76.


Dental health and lung cancer risk in the Golestan Cohort Study.

Yano Y, Abnet C, Roshandel G, Graf A, Poustchi H, Khoshnia M BMC Cancer. 2024; 24(1):74.

PMID: 38218793 PMC: 10787979. DOI: 10.1186/s12885-024-11850-5.